Recommended Home Dose of Zofran (Ondansetron)
For adults, the standard home dose of ondansetron is 8 mg orally twice daily (every 12 hours) for chemotherapy-induced nausea, 8 mg three times daily for radiation-induced nausea, or 16 mg as a single dose for postoperative nausea; for children 4-11 years old, use 4 mg three times daily for chemotherapy-induced nausea, and for children ≥12 years, use the adult dosing. 1
Adult Dosing by Indication
Chemotherapy-Induced Nausea and Vomiting
Highly Emetogenic Chemotherapy (e.g., cisplatin ≥50 mg/m²):
- Initial dose: 24 mg (three 8 mg tablets) given 30 minutes before chemotherapy 1
- Home continuation: 8 mg orally twice daily on days 2-4 after chemotherapy 2
- This regimen is supported by ASCO guidelines showing ondansetron 8 mg twice daily provides effective control when combined with other antiemetics 2
Moderately Emetogenic Chemotherapy:
- Day 1: 8 mg given 30 minutes before chemotherapy, then 8 mg eight hours later 1
- Days 2-3: 8 mg twice daily (every 12 hours) for 1-2 days after completion of chemotherapy 1
- ASCO guidelines confirm this dosing for moderate-risk chemotherapy regimens 2
Radiation-Induced Nausea and Vomiting
Total Body Irradiation or Abdominal Radiation:
- 8 mg orally three times daily 1
- First dose: 1-2 hours before each radiation fraction 2
- Subsequent doses: Every 8 hours after the first dose 2
- Continue once daily on days after radiation therapy if no radiation is planned 3, 2
Low-Risk Radiation (brain, head/neck, thorax, pelvis):
- 8 mg orally as breakthrough therapy, titrate up to maximum of 16 mg daily 2
Postoperative Nausea and Vomiting
- 16 mg as a single dose (two 8 mg tablets) given 1 hour before induction of anesthesia 1
- No established home continuation dosing for postoperative nausea 1
Pediatric Dosing
Children 4-11 Years Old
Moderately Emetogenic Chemotherapy:
- 4 mg orally three times daily 1
- First dose: 30 minutes before chemotherapy 1
- Subsequent doses: 4 and 8 hours after first dose on day 1 1
- Home continuation: 4 mg three times daily (every 8 hours) for 1-2 days after chemotherapy completion 1
Children ≥12 Years Old
- Use adult dosing: 8 mg twice daily for moderately emetogenic chemotherapy 1
Gastroenteritis (Off-Label but Common)
- Dose range: 0.13-0.26 mg/kg has shown efficacy without dose-dependent differences 4
- Recent evidence supports multidose ondansetron after emergency visits, reducing moderate-to-severe gastroenteritis risk 5
- Typical practical dosing: 4 mg for children <30 kg, 8 mg for children ≥30 kg, given as needed for vomiting 5
Important Formulation Notes
Available oral formulations include: 1
- Standard tablets (8 mg)
- Orally disintegrating tablets (4 mg, 8 mg) - dissolve on tongue in seconds, no liquid needed
- Oral soluble films (8 mg)
Administration instructions for orally disintegrating tablets: 1
- Use dry hands to remove tablet
- Place immediately on tongue where it dissolves in seconds
- Swallow with saliva; liquid not necessary
Critical Dosing Caveats
Maximum daily dose considerations:
- The 24 mg single-dose regimen for highly emetogenic chemotherapy should only be used on day 1 1
- Multiday administration of 24 mg single doses has not been studied and is not recommended 1
- For breakthrough therapy, maximum is 16 mg daily 2
Hepatic impairment:
- No specific dose adjustment recommended in FDA labeling, though ondansetron undergoes extensive hepatic metabolism 1
Renal impairment:
Pediatric limitations:
- No experience with 24 mg dosing in pediatric patients 1
- No established dosing for radiation-induced or postoperative nausea in children 1
Combination Therapy Considerations
When ondansetron is combined with NK1 antagonists or corticosteroids (as in ASCO guidelines), the home continuation typically involves: 2
- Ondansetron 8 mg twice daily on days 2-4
- This is part of multimodal antiemetic prophylaxis for high-risk chemotherapy
- The combination approach significantly improves complete response rates compared to ondansetron alone 2